An interview with Neil
EVOLVA: an Interview with CEO Neil Goldsmith
— Daniela Quaglia (@Dny_Q) April 2, 2017
Founded in 2004, Evolva is one of the first synthetic biology companies ever created, and it is a beautiful example of a successful business in our field. Evolva employs more than 175 people around the globe and since 2009 it has been listed on the Swiss Stock Exchange (SIX: EVE). Evolva’s CEO Neil Goldsmith kindly agreed to walk us through the company’s history, goals, and philosophy in a very inspiring interview.
A bit of history
At the time in which Evolva was founded people were not speaking much about synthetic biology, at least using this terminology. As Goldsmith points out:
‘We actually did not know that we were setting up a synthetic biology company because the term was not really in use. At the time we called what we did ‘genetic chemistry’.
Read the full article on the PLOS Blog